English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

NIH awards $3.2 million grant to study thymulin's role in inflammaging and cancer
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Researchers urge improved safety testing for lip cosmetics after regulatory review
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Korean study finds no overall childhood cancer link with maternal diabetes
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

NIH funds smartphone platform to improve driving safety for teens with ADHD
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Pathos announces cancer drug partnerships with AstraZeneca and Jiangsu Alphamab
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
Patient Daily | Aug 4, 2026

American Association of Nurse Practitioners announces 2026 National NP Week events and resources
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Northwestern Memorial Hospital maintains U.S. News Honor Roll status for 15th year

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'